Erlotib is a medication that is used to treat non-small cell lung cancer (NSCLC). The active ingredient in Erlotib is Erlotinib, which belongs to the class of drugs known as tyrosine kinase inhibitors. It works by blocking the action of a protein known as the epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells.
Erlotib is used to treat NSCLC in patients who have not responded to other treatments or who have a specific type of EGFR mutation. It is also used in combination with other medications to treat advanced pancreatic cancer.
HOW TO USE:
Erlotib should be taken as directed by the doctor. It should be taken on an empty stomach, at least one hour before or two hours after a meal. The tablets should be swallowed whole with a glass of water. Patients should not crush, chew, or break the tablets before swallowing them.
Erlotib tablets should be stored at room temperature, away from direct sunlight, and out of the reach of children. The tablets should be kept in their original packaging until they are ready to be used.
Mechanism of action:
Erlotinib works by inhibiting the action of the EGFR protein, which is involved in the growth and spread of cancer cells. By blocking the action of this protein, Erlotinib can slow down or stop the growth of cancer cells in the body.
Before using Erlotib, patients should inform their doctor if they have any pre-existing medical conditions, including liver or kidney disease. Patients should also inform their doctor if they are pregnant or breastfeeding.
Erlotib should not be used in patients who are allergic to Erlotinib or any of the other ingredients in the medication. It should also not be used in patients with severely reduced liver function.
Erlotib may interact with other medications, including some antibiotics, antifungal drugs, and heart medications. Patients should inform their doctor of all medications they are taking, including over-the-counter medicines, vitamins, and herbal supplements.
If an overdose of Erlotib is suspected, patients should seek immediate medical attention. Symptoms of an overdose may include diarrhea, rash, and liver damage.
Erlotib may cause some side effects, including:
4. Loss of appetite
5. Nausea and vomiting
Patients should inform their doctor if they experience any side effects while taking this medication.